Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by wolfy2424on Mar 20, 2016 5:52pm
293 Views
Post# 24681480

What other possibilities for Plasminogen?

What other possibilities for Plasminogen? As discussed by management that plasminogen may be far bigger than they previously expected - anyone have any insights or guesses as to what other indications plasminogen may be used for?

So far it has been found to be very effective against diabetic ulcers in testing

If that is the case, then there have to be other types of wounds or situations that it could be effective - including burns, other forms of ulcers in the body, skin eating diseases among others

Obviously they cannot test for all these at once and choosing diabetic wounds is a multi billion dollar market and a great choice to start at - if it works the company is worth 10 times more at least

Does anyone here have any insights as to the other possible indications that may come in the next 5 years as cash flow issues are a thing of the past for prometic?  


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse